Community/Retail

This weekly video program provides our readers with an in-depth review of the latest news, product approvals, FDA rulings and more.

There was some degree of unmet demand for pharmacists nationally in January and December, which was a slight improvement from November, when the number of pharmacists looking for work seemed to exceed the number of pharmacist jobs available.

The FDA has approved Eli Lilly and Company's ixekizumab (Taltz) as a treatment for moderate to severe plaque psoriasis.

Children's Miracle Network Hospitals is proud to announce that is has partnered with United Networks of America, one of the largest providers of value-added managed care products and services in the country.

Older adults are increasingly putting themselves at risk for adverse effects by concurrently taking multiple prescription drugs and supplements.

You're not being paid to do everything right. You're being paid to do just one thing right.

Pharmacists should be aware of the latest drug trend report from the nation's largest pharmacy benefits manager to better inform patients of any shifts in pricing.

Bristol-Myers Squibb recently announced that it's acquiring Padlock Therapeutics, Inc.

A potential addition to technology-based diabetes care is transdermal metformin.

Patients receiving follow-up care more than 6 weeks after a heart attack are much less likely to stick to their medication regimen.

A pharmacy error turned fatal after a staff member allegedly dispensed Florence Frost's medication to an 86-year-old patient named Margaret Forrest.

Mother-to-child HIV transmission drives pediatric AIDS incidence, and risk of transmission increases as the mother's viral load increases.

Failure is a hard thing to admit.

A multifaceted collaboration of health care professionals, including pharmacists, prescribers, and patients, are working together to reduce the impact of this crisis.

State regulation of telepharmacy varies depending on the market-driven needs within each particular state.

The FDA is proposing a ban on powdered gloves in most medical situations.

A pair of North Dakota State University (NDSU) pharmacy students won first prize and the People's Choice Award at the school's 2016 Innovation Challenge.

John Fanikos, RPh, MBA, director of pharmacy at Brigham and Women's Hospital, discusses new trends pharmacists should know about atrial fibrillation management.

Michael Cawley, BS, PharmD, RRT, CPFT, FCCM, professor of clinical pharmacy at the University of the Sciences, demonstrates proper technique for inhaler devices.

Patients with severe asthma now have a new treatment option: reslizumab (Cinqair).

An act to restrict direct-to-consumer advertising was recently referred to the House Committee on Energy and Commerce.

The game-changing property of these antibiotics is their one-time dosing.

Did you know that gout has been recognized as a disease since 2640 BC?

Aralez Pharmaceuticals Inc resubmitted its new drug application to the FDA for its investigational candidate PA32540/PA8140 as secondary prevention of cardiovascular disease in patients at risk for aspirin-induced gastric ulcers.

Dennis Williams, PharmD, FAPhA, discusses the existing pharmacotherapy and immunotherapy options for managing allergic rhinitis.

Buprenorphine is now available in several dosage forms with various indications.

The FDA is requiring a new boxed warning for all immediate-release opioids that outlines the serious risks of opioid misuse, abuse, addiction, overdose, and death.

A recent ProPublica analysis found that physicians who receive payments from drug companies may exhibit different prescribing patterns with respect to brand-name medications.

The results of this year's pharmacy residency Match have been released, stirring up a range of emotions among applicants across the country.

Physicians and pharmacists usually work well together as part of a patient's care team, but there are some things that many physicians would prefer pharmacists not to know.